Search in:

ImmunoTargets and Therapy Volume 10, 2021 - Issue

Submit an article Journal homepage

Open access

374

Views

CrossRef citations to date

Altmetric

Review

NHS-IL12, a Tumor-Targeting Immunocytokine

John W GreinerLaboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USAView further author information

Y Maurice Morillon IILaboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USAView further author information

Jeffrey SchlomLaboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USACorrespondence[email protected]

https://orcid.org/0000-0001-7932-4072 View further author information

Pages 155-169 | Published online: 27 May 2021

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (14)

S. Elizabeth Franks, Ginette S. Santiago-Sanchez, Kellsye P. Fabian, Kristen Solocinski, Paul L. Chariou, Duane H. Hamilton, Joshua T. Kowalczyk, Michelle R. Padget, Sofia R. Gameiro, Jeffrey Schlom & James W. Hodge. (2023) Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12. Cancer Immunology, Immunotherapy 72:8, pages 2783-2797.
Crossref

Linus Kruk, Medina Mamtimin, Attila Braun, Hans-Joachim Anders, Joachim Andrassy, Thomas Gudermann & Elmina Mammadova-Bach. (2023) Inflammatory Networks in Renal Cell Carcinoma. Cancers 15:8, pages 2212.
Crossref

Nicole J. Toney, Margaret E. Gatti-Mays, Nicholas P. Tschernia, Julius Strauss, James L. Gulley, Jeffrey Schlom & Renee N. Donahue. (2023) Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12. International Immunopharmacology 116, pages 109736.
Crossref

Keunok Jung, Sojung Yoo, Jung-Eun Kim, Wook Kim & Yong-Sung Kim. (2022) Improved intratumoral penetration of IL12 immunocytokine enhances the antitumor efficacy. Frontiers in Immunology 13.
Crossref

Theresa Schneider, Lei Zhao, Ziwen Zhu, Gagik Gabrielyan, Huaping Xiao, Emerson D. Fajardo, Qian Bai, Mark R. Wakefield & Yujiang Fang. (2022) The past, present, and future of immunotherapy for bladder tumors. Medical Oncology 39:12.
Crossref

Ginette S. Santiago-Sánchez, James W. Hodge & Kellsye P. Fabian. (2022) Tipping the scales: Immunotherapeutic strategies that disrupt immunosuppression and promote immune activation. Frontiers in Immunology 13.
Crossref

Sofia R Gameiro, Julius Strauss, James L Gulley & Jeffrey Schlom. (2022) Preclinical and clinical studies of bintrafusp alfa, a novel bifunctional anti-PD-L1/TGFβRII agent: Current status. Experimental Biology and Medicine 247:13, pages 1124-1134.
Crossref

Rilan Bai & Jiuwei Cui. (2022) Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing. Frontiers in Immunology 13.
Crossref

Keywan Mortezaee & Jamal Majidpoor. (2022) Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy. Cellular Oncology 45:3, pages 333-353.
Crossref

Spyridon Gougousis, Savvas Petanidis, Alexandros Poutoglidis, Nikolaos Tsetsos, Paraskevas Vrochidis, Ioannis Skoumpas, Nektarios Argyriou, Theodora Katopodi & Kalliopi Domvri. (2022) Epigenetic editing and tumor‑dependent immunosuppressive signaling in head and neck malignancies (Review). Oncology Letters 23:6.
Crossref

David J. Propper & Frances R. Balkwill. (2022) Harnessing cytokines and chemokines for cancer therapy. Nature Reviews Clinical Oncology 19:4, pages 237-253.
Crossref

Patrick G. Holder, Shion A. Lim, Christine S. Huang, Preeti Sharma, Yavuz S. Dagdas, Beyza Bulutoglu & Jonathan T. Sockolosky. (2022) Engineering interferons and interleukins for cancer immunotherapy. Advanced Drug Delivery Reviews 182, pages 114112.
Crossref

Shelby A. Fertal, Johanna E. Poterala, Suzanne M. Ponik & Kari B. Wisinski. (2022) Stromal Characteristics and Impact on New Therapies for Metastatic Triple-Negative Breast Cancer. Cancers 14:5, pages 1238.
Crossref

Luis E. Munoz, Lenore Monterroza, Ramireddy Bommireddy, Yalda Shafizadeh, Christopher D. Pack, Sampath Ramachandiran, Shaker J. C. Reddy & Periasamy Selvaraj. (2021) Dendritic Cells Pulsed with Cytokine-Adjuvanted Tumor Membrane Vesicles Inhibit Tumor Growth in HER2-Positive and Triple Negative Breast Cancer Models. International Journal of Molecular Sciences 22:16, pages 8377.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

NHS-IL12, a Tumor-Targeting Immunocytokine

Articles from other publishers (14)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

NHS-IL12, a Tumor-Targeting Immunocytokine

Citations (14)

Articles from other publishers (14)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date